from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3686c/-

LFCtreatmentdescriptionclass of inhibitor

1.768

Amikacinug/mL Amikacintranslation

1.874

Cap5-10ug/mL Capreomycintranslation

2.135

Rox10-50 ug/mL Roxithromycintranslation

0.270

SM2-5 ug/mL Streptomycintranslation

2.851

Tet5-10 ug/mL Tetracyclinetranslation

-0.019

Rif0.2-5ug/mL Rifampicintranscription

-0.010

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.419

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.598

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.768

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.298

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.006

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.467

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.429

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.553

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.008

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.475

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.236

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.710

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.600

KCN5-20 ug/mL Potassium cyaniderespiration

-0.583

NaN30.2-2 mM Sodium aziderespiration

0.546

Nigericin50 uM Nigericinrespiration

-0.966

TRC10-150 ug/mL Triclosanrespiration

-1.394

TRZ10-25 ug/mL Thioridazinerespiration

-0.719

Valinomycin0.5-10 uM Valinomycinrespiration

0.394

ZnSO42 mM ZnSO4respiration

-0.557

menadione6-10 ug/mL Menadionerespiration

0.183

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.491

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.073

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.312

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.206

NRP_1Non-replicating persistence stage 1dosRassociated

0.730

Amp0.2mg/mL AmpicillincellWall

0.168

Cephalexin20-100 ug/mL CephalexincellWall

0.359

Cerulenin0.32-5 ug/mL CerulenincellWall

0.213

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.640

EMB10-20 ug/mL EthambutolcellWall

0.736

Eta12-40 ug/mL EthionamidecellWall

0.849

INH0.2-0.4 ug/mL IsoniazidcellWall

0.222

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.704

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.659

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.820

BZA0.12 mg/mL BenzamidearomaticAmides

-0.762

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.299

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.236

H2O24 mM hydrogen peroxideDNAdamaging

0.044

Levo10 ug/mL LevofloxacinDNAdamaging

0.299

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.953

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.050

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.593

UVUV-irradiationDNAdamaging

-0.861

ARP41-4 ug/mL Antitubercular compound ARP4?

0.319

Antimycin12.5-50 ug/mL Antimycin A?

0.443

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.551

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.131

PA8240.2-2 ug/mL PA-824?

-1.202

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.236

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.915

Verapamil50 uM Verapamil?

0.363

mercaptoethanol2 mM 2-Mercaptoethanol?

0.416

methoxatin10-20 ug/mL Methoxatin?